Výsledky vyhledávání - "Vandenbossche J"

Akademický článek

A superimposed cohesive zone model for investigating the fracture properties of concrete-asphalt interface debonding.

Autor: Mu, F¹ fengmu82@gmail.com, Vandenbossche, J²

Publikováno v: Fatigue & Fracture of Engineering Materials & Structures. Apr2017, Vol. 40 Issue 4, p496-511. 16p. 8 Diagrams, 3 Charts, 5 Graphs.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Repeat-dose steady-state pharmacokinetic evaluation of once-daily hydromorphone extended-release (OROS® hydromorphone ER) in patients with chronic pain

Autor: Vandenbossche J, Richarz U, Richards HM

Publikováno v: Journal of Pain Research, Vol 2012, Iss default, Pp 523-533 (2012)

Joris Vandenbossche,1 Ute Richarz,2 Henry M Richards31Clinical Pharmacology, Johnson and Johnson Pharmaceutical Research and Development, Beerse, Belgium; 2Global Medical Affairs, Janssen-Cilag, Baar, Switzerland; 3Established Products, Johnson and J

Externí odkaz: https://doaj.org/article/ea300eb1c72846d78f6c55c16c970154

Zobrazit plný text záznamu

Akademický článek

Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection.

Autor: Janssen HLA; Toronto General Hospital, Toronto, Ontario, Canada.; Erasmus Medical Center, Rotterdam, Zuid-Holland, The Netherlands., Hou J; Nanfang Hospital, Southern Medical University, Guangzhou, China., Asselah T; Université de Paris Cité, INSERM UMR1149, Hôpital Beaujon AP-HP, Clichy, France., Chan HLY; The Chinese University of Hong Kong, Hong Kong SAR, China., Zoulim F; Hospices Civils de Lyon and Lyon University & INSERM U1052-Cancer Research Institute of Lyon, Lyon, France., Tanaka Y; Department of Gastroenterology and Hepatology, Kumamoto University, Kumamoto, Japan., Janczewska E; Faculty of Health Sciences in Bytom, Medical University of Silesia, Katowice, Poland., Nahass RG; ID Care, Hillsborough, New Jersey, USA., Bourgeois S; ZNA Jan Palfijn, CPU, Antwerp, Belgium., Buti M; Hospital Universitario Vall d'Hebrón and CIBERHED del Instituto Carlos III, Barcelona, Spain., Lampertico P; Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Pathophysiology and Transplantation, CRC 'A. M. and A. Migliavacca' Center for Liver Disease, University of Milan, Milan, Italy., Lenz O; Janssen Pharmaceutica NV, Beerse, Belgium., Verbinnen T; Janssen Pharmaceutica NV, Beerse, Belgium., Vandenbossche J; Janssen Pharmaceutica NV, Beerse, Belgium., Talloen W; Janssen Pharmaceutica NV, Beerse, Belgium., Kalmeijer R; Janssen Pharmaceuticals R&D, Titusville, New Jersey, USA., Beumont M; Janssen Pharmaceuticals R&D, Titusville, New Jersey, USA., Biermer M; Janssen Pharmaceutica NV, Beerse, Belgium mbiermer@its.jnj.com., Shukla U; Janssen Pharmaceuticals R&D, Titusville, New Jersey, USA.

Publikováno v: Gut [Gut] 2023 Jul; Vol. 72 (7), pp. 1385-1398. Date of Electronic Publication: 2023 Jan 25.

Zobrazit plný text záznamu

Akademický článek

A single, oral dose of the TLR7 agonist JNJ-64794964 induces transcriptomic and phenotypic changes in peripheral immune cells in healthy adults.

Autor: Pierson W; Janssen Pharmaceutica NV, Beerse, Belgium., Tuefferd M; Janssen Pharmaceutica NV, Beerse, Belgium., Herschke F; Janssen Pharmaceutica NV, Beerse, Belgium., Slaets L; Janssen Pharmaceutica NV, Beerse, Belgium., Crabbe M; Janssen Pharmaceutica NV, Beerse, Belgium., Verstappen D; Janssen Pharmaceutica NV, Beerse, Belgium., De Pelsmaeker S; Janssen Pharmaceutica NV, Beerse, Belgium., Strickland I; Janssen Pharmaceutica NV, Beerse, Belgium., Gane EJ; New Zealand Liver Transplant Unit, University of Auckland, Auckland, New Zealand., Schwabe C; Auckland Clinical Studies, Auckland, New Zealand., Zhang Y; Open Analytics NV, Antwerp, Belgium., Meerts P; Janssen Pharmaceutica NV, Beerse, Belgium., Vandenbossche J; Janssen Pharmaceutica NV, Beerse, Belgium., Van Remoortere P; Janssen Research and Development LLC, Titusville, NJ, USA., Verbrugge I; Janssen Pharmaceutica NV, Beerse, Belgium., De Creus A; Janssen Pharmaceutica NV, Beerse, Belgium.

Publikováno v: Antiviral therapy [Antivir Ther] 2023 Jun; Vol. 28 (3), pp. 13596535231172878.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání